7. Как не умереть от гипертонии
‹‹1››. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–128.
‹‹2››. Das P, Samarasekera U. The story of GBD 2010: a «super-human» eff ort. Lancet. 2012; 380 (9859):2067–70.
‹‹3››. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224–60.
‹‹4››. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224–60.
‹‹5››. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224–60.
‹‹6››. Bromfield S, Muntner P. High blood pressure: the leading global burden of disease risk factor and the need for worldwide prevention programs. Curr Hypertens Rep. 2013;15(3):134–6.
‹‹7››. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224–60.
‹‹8››. American Heart Association. Understanding Blood Pressure Readings. http://www.heart.org/HEARTORG/Conditions/HighBloodPressure/AboutHighBloodPressure/Understanding-Blood-Pressure-Readings_ UCM_301764_Article.jsp. March 11, 2015. Accessed March 11, 2015.
‹‹9››. Go AS, Bauman MA, Coleman King SM, et al. An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention. J Am Coll Cardiol. 2014;63(12): 1230–8.
‹‹10››. Nwankwo T, Yoon SS, Burt V, Gu Q. Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011–2012. NCHS Data Brief. 2013;(133):1–8.
‹‹11››. Walker AR, Walker BF. High high-density-lipoprotein cholesterol in African children and adults in a population free of coronary heart diseae. Br Med J. 1978;2(6148):1336–7.
‹‹12››. Donnison CP. Blood pressure in the African native. Lancet. 1929;213(5497):6–7.
‹‹13››. Macmahon S, Neal B, Rodgers A. Hypertension— time to move on. Lancet. 2005;365(9464): 1108–9.
‹‹14››. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665.
‹‹15››. Donnison CP. Blood pressure in the African native. Lancet. 1929;213(5497):6–7.
‹‹16››. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224–60.
‹‹17››. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224–60.
‹‹18››. Karppanen H, Mervaala E. Sodium intake and hypertension. Prog Cardiovasc Dis. 2006;49(2): 59–75.
‹‹19››. Delahaye F. Should we eat less salt? Arch Cardiovasc Dis. 2013;106(5):324–32.
‹‹20››. Jenkins DJ, Kendall CW. The garden of Eden: plant-based diets, the genetic drive to store fat and conserve cholesterol, and implications for epidemiology in the 21st century. Epidemiology. 2006;17(2):128–30.
‹‹21››. Roberts WC. High salt intake, its origins, its economic impact, and its Effect on blood pressure. Am J Cardiol. 2001;88(11):1338–46.
‹‹22››. Roberts WC. High salt intake, its origins, its economic impact, and its Effect on blood pressure. Am J Cardiol. 2001;88(11):1338–46.
‹‹23››. Celermajer DS, Neal B. Excessive sodium intake and cardiovascular disease: a-salting our vessels. J Am Coll Cardiol. 2013;61(3):344–5.
‹‹24››. Whelton PK, Appel LJ, Sacco RL, et al. Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations. Circulation. 2012;126(24):2880–9.
‹‹25››. Centers for Disease Control and Prevention. Sodium intake among adults-United States, 2005–2006. MMWR Morb Mortal Wkly Rep. 2010;59(24):746–9.
‹‹26››. Beaglehole R, Bonita R, Horton R, et al. Priority actions for the non-communicable disease crisis. Lancet. 2011;377(9775):1438–47.
‹‹27››. Law MR, Frost CD, Wald NJ. By how much does dietary salt reduction lower blood pressure? III— Analysis of data from trials of salt reduction. BMJ. 1991;302(6780):819–24.
‹‹28››. Bibbins-Domingo K, Chertow GM, Coxson PG, et al. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med. 2010 Feb 18;362(7):590–9.
‹‹29››. MacGregor GA, Markandu ND, Best FE, et al. Double-blind randomised crossover trial of moderate sodium restriction in essential hypertension. Lancet. 1982;1(8268):351–5.
‹‹30››. MacGregor GA, Markandu ND, Sagnella GA, Singer DR, Cappuccio FP. Double-blind study of three sodium intakes and long-term effects of sodium restriction in essential hypertension. Lancet. 1989;2(8674):1244–7.
‹‹31››. MacGregor GA, Markandu ND, Sagnella GA, Singer DR, Cappuccio FP. Double-blind study of three sodium intakes and long-term effects of sodium restriction in essential hypertension. Lancet. 1989;2(8674):1244–7.
‹‹32››. Rudelt A, French S, Harnack L. Fourteen-year trends in sodium content of menu offerings at eight leading fast-food restaurants in the USA. Public Health Nutr. 2014;17(8):1682–8.
‹‹33››. Suckling RJ, He FJ, Markandu ND, MacGregor GA. Dietary salt influences postprandial plasma sodium concentration and systolic blood pressure. Kidney Int. 2012;81(4):407–11.
‹‹34››. He FJ, Li J, MacGregor GA. Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials. BMJ. 2013;346:f1325.
‹‹35››. Celermajer DS, Neal B. Excessive sodium intake and cardiovascular disease: a-salting our vessels. J Am Coll Cardiol. 2013;61(3):344–5.
‹‹36››. Oliver WJ, Cohen EL, Neel JV. Blood pressure, sodium intake, and sodium related hormones in the Yanomamo Indians, a «no-salt» culture. Circulation. 1975;52(1):146–51.
‹‹37››. Mancilha-Carvalho J de J, de Souza e Silva NA. The Yanomami Indians in the INTERSALT Study. Arq Bras Cardiol. 2003;80(3):289–300.
‹‹38››. Celermajer DS, Neal B. Excessive sodium intake and cardiovascular disease: a-salting our vessels. J Am Coll Cardiol. 2013;61(3):344–5.
‹‹39››. Mancilha-Carvalho J de J, de Souza e Silva NA. The Yanomami Indians in the INTERSALT Study. Arq Bras Cardiol. 2003;80(3):289–300.
‹‹40››. Mancilha-Carvalho J de J, Crews DE. Lipid profiles of Yanomamo Indians of Brazil. Prev Med. 1990;19(1):66–75.
‹‹41››. Kempner W. Treatment of heart and kidney disease and of hypertensive and arteriosclerotic vascular disease with the rice diet. Ann Intern Med. 1949;31(5):821–56.
‹‹42››. Klemmer P, Grim CE, Luft FC. Who and what drove Walter Kempner? The rice diet revisited. Hypertension. 2014;64(4):684–8.
‹‹43››. Kempner W. Treatment of heart and kidney disease and of hypertensive and arteriosclerotic vascular disease with the rice diet. Ann Intern Med. 1949;31(5):821–56.
‹‹44››. Roberts WC. High salt intake, its origins, its economic impact, and its effect on blood pressure. Am J Cardiol. 2001;88(11):1338–46.
‹‹45››. Dickinson KM, Clifton PM, Keogh JB. Endothelial function is impaired after a high-salt meal in healthy subjects. Am J Clin Nutr. 2011;93(3):500–5.
‹‹46››. DuPont JJ, Greaney JL, Wenner MM, et al. High dietary sodium intake impairs endotheliumdependent dilation in healthy salt-resistant humans. J Hypertens. 2013;31(3):530–6.
‹‹47››. Dickinson KM, Clifton PM, Keogh JB. Endothelial function is impaired after a high-salt meal in healthy subjects. Am J Clin Nutr. 2011;93(3):500–5.
‹‹48››. Greaney JL, DuPont JJ, Lennon-Edwards SL, Sanders PW, Edwards DG, Farquhar WB. Dietary sodium loading impairs microvascular function independent of blood pressure in humans: role of oxidative stress. J Physiol (Lond). 2012;590(Pt 21):5519–28.
‹‹49››. Jablonski KL, Racine ML, Geolfos CJ, et al. Dietary sodium restriction reverses vascular endothelial dysfunction in middle-aged/older adults with moderately elevated systolic blood pressure. J Am Coll Cardiol. 2013;61(3):335–43.
‹‹50››. McCord JM. Analysis of superoxide dismutase activity. Curr Protoc Toxicol. 1999;Chapter 7: Unit 7.3.
‹‹51››. Dickinson KM, Clifton PM, Burrell LM, Barrett PHR, Keogh JB. Postprandial effects of a high salt meal on serum sodium, arterial stiffness, markers of nitric oxide production and markers of endothelial function. Atherosclerosis. 2014;232(1):211–6.
‹‹52››. Huang Ti Nei Ching Su Wua [The Yellow Emperor’s Classic of Internal Medicine] (Veith I, Trans.) Oakland, CA: University of California Press; 1972:141.
‹‹53››. Hanneman RL, Satin M. Comments to the Dietary Guidelines Committee on behalf of the Salt Institute. Comment ID: 000447. April 23, 2009.
‹‹54››. Vital signs: food categories contributing the most to sodium consumption-United States, 2007–2008. MMWR Morb Mortal Wkly Rep. 2012;61(5):92–8.
‹‹55››. Miller GD. Comments to the Dietary Guidelines Committee on behalf of the National Dairy Council, July 27, 2009.
‹‹56››. Roberts WC. High salt intake, its origins, its economic impact, and its effect on blood pressure. Am J Cardiol. 2001;88(11):1338–46.
‹‹57››. MacGregor G, de Wardener HE. Salt, blood pressure and health. Int J Epidemiol. 2002; 31(2):320–7.
‹‹58››. Appel LJ, Anderson CAM. Compelling evidence for public health action to reduce salt intake. N Engl J Med. 2010;362(7):650–2.
‹‹59››. Roberts WC. High salt intake, its origins, its economic impact, and its effect on blood pressure. Am J Cardiol. 2001;88(11):1338–46.
‹‹60››. Buying this chicken? Consum Rep. June 2008;7.
‹‹61››. Drewnowski A, Rehm CD. Sodium intakes of US children and adults from foods and beverages by location of origin and by specific food source. Nutrients. 2013;5(6):1840–55.
‹‹62››. U.S. Department of Agriculture, Agricultural Research Ser vice. 2014. USDA National Nutrient Database for Standard Reference, Release 27. Pizza Hut 14? pepperoni pizza, pan crust. http://ndb.nal.usda.gov/ndb/foods/show/6800. Accessed March 22, 2015.
‹‹63››. Drewnowski A, Rehm CD. Sodium intakes of US children and adults from foods and beverages by location of origin and by specific food source. Nutrients. 2013;5(6):1840–55.
‹‹64››. Blais CA, Pangborn RM, Borhani NO, Ferrell MF, Prineas RJ, Laing B. Effect of dietary sodium restriction on taste responses to sodium chloride: a longitudinal study. Am J Clin Nutr. 1986;44(2):232–43.
‹‹65››. Tucker RM, Mattes RD. Are free fatty acids effective taste stimuli in humans? Presented at the symposium «The Taste for Fat: New Discoveries on the Role of Fat in Sensory Perception, Metabolism, Sensory Pleasure and Beyond» held at the Institute of Food Technologists 2011 Annual Meeting, New Orleans, LA, June 12, 2011. J Food Sci. 2012;77(3):S148–51.
‹‹66››. Grieve FG, Vander Weg MW. Desire to eat high-and low-fat foods following a low-fat dietary intervention. J Nutr Educ Behav. 2003;35(2):98–102.
‹‹67››. Stewart JE, Newman LP, Keast RS. Oral sensitivity to oleic acid is associated with fat intake and body mass index. Clin Nutr. 2011;30(6):838–44.
‹‹68››. Stewart JE, Keast RS. Recent fat intake modulates fat taste sensitivity in lean and overweight subjects. Int J Obes (Lond). 2012;36(6):834–42.
‹‹69››. Roberts WC. High salt intake, its origins, its economic impact, and its effect on blood pressure. Am J Cardiol. 2001;88(11):1338–46.
‹‹70››. Newson RS, Elmadfa I, Biro G, et al. Barriers for progress in salt reduction in the general population. An international study. Appetite. 2013;71:22–31.
‹‹71››. Cappuccio FP, Capewell S, Lincoln P, McPherson K. Policy options to reduce population salt intake. BMJ. 2011;343:d4995.
‹‹72››. Toldr? F, Barat JM. Strategies for salt reduction in foods. Recent Pat Food Nutr Agric. 2012; 4(1):19–25.
‹‹73››. Lin B-H, Guthrie J. Nutritional Quality of Food Prepared at Home and Away from Home, 1977–2008. USDA, Economic Research Ser vice, December 2012.
‹‹74››. Newson RS, Elmadfa I, Biro G, et al. Barriers for progress in salt reduction in the general population. An international study. Appetite. 2013;71:22–31.
‹‹75››. Roberts WC. High salt intake, its origins, its economic impact, and its effect on blood pressure. Am J Cardiol. 2001;88(11):1338–46.
‹‹76››. U.S. Department of Agriculture and U.S. Department of Health and Human Services. Dietary Guidelines for Americans, 2010. 7th Edition, Washington, D.C.: US Government Printing Office, December 2010.
‹‹77››. Karppanen H, Mervaala E. Sodium intake and hypertension. Prog Cardiovasc Dis. 2006;49(2): 59–75.
‹‹78››. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665.
‹‹79››. Tighe P, Duthie G, Vaughan N, et al. Effect of increased consumption of whole-grain foods on blood pressure and other cardiovascular risk markers in healthy middle-aged persons: a randomized controlled trial. Am J Clin Nutr. 2010;92(4):733–40.
‹‹80››. Diaconu CC, Balaceanu A, Bartos D. Diuretics, first-line antihypertensive agents: are they always safe in the elderly? Rom J Intern Med. 2014;52(2):87–90.
‹‹81››. Li CI, Daling JR, Tang MT, Haugen KL, Porter PL, Malone KE. Use of antihypertensive medications and breast cancer risk among women aged 55 to 74 years. JAMA Intern Med. 2013; 173(17):1629–37.
‹‹82››. Kaiser EA, Lotze U, Schiser HH. Increasing complexity: which drug class to choose for treatment of hypertension in the elderly? Clin Interv Aging. 2014;9:459–75.
‹‹83››. Rasmussen ER, Mey K, Bygum A. Angiotensin-converting enzyme inhibitor-induced angioedema — a dangerous new epidemic. Acta Derm Venereol. 2014;94(3):260–4.
‹‹84››. Tinetti ME, Han L, Lee DS, et al. Antihypertensive medications and serious fall injuries in a nationally representative sample of older adults. JAMA Intern Med. 2014;174(4):588–95.
‹‹85››. Ye EQ, Chacko SA, Chou EL, Kugizaki M, Liu S. Greater whole-grain intake is associated with lower risk of type 2 diabetes, cardiovascular disease, and weight gain. J Nutr. 2012;142(7): 1304–13.
‹‹86››. Aune D, Chan DS, Lau R, et al. Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies. BMJ. 2011;343:d6617.
‹‹87››. Tighe P, Duthie G, Vaughan N, et al. Effect of increased consumption of whole-grain foods on blood pressure and other cardiovascular risk markers in healthy middle-aged persons: a randomized controlled trial. Am J Clin Nutr. 2010;92(4):733–40.
‹‹88››. Sun Q, Spiegelman D, van Dam RM, et al. White rice, brown rice, and risk of type 2 diabetes in US men and women. Arch Intern Med. 2010;170(11):961–9.
‹‹89››. Ye EQ, Chacko SA, Chou EL, Kugizaki M, Liu S. Greater whole-grain intake is associated with lower risk of type 2 diabetes, cardiovascular disease, and weight gain. J Nutr. 2012;142(7): 1304–13.
‹‹90››. Mellen PB, Liese AD, Tooze JA, Vitolins MZ, Wagenknecht LE, Herrington DM. Wholegrain intake and carotid artery atherosclerosis in a multiethnic cohort: the Insulin Resistance Atherosclerosis Study. Am J Clin Nutr. 2007;85(6):1495–502.
‹‹91››. Erkkil? AT, Herrington DM, Mozaffarian D, et al. Cereal fiber and whole-grain intake are associated with reduced progession of coronary-artery atherosclerosis in postmenopausal women with coronary artery disease. Am Heart J. 2005;150(1):94–101.
‹‹92››. Go AS, Bauman MA, Coleman King SM, et al. An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention. J Am Coll Cardiol. 2014;63(12): 1230–8.
‹‹93››. Mahmud A, Feely J. Low-dose quadruple antihypertensive combination: more efficacious than individual agents— a preliminary report. Hypertension. 2007;49(2):272–5.
‹‹94››. Kronish IM, Woodward M, Sergie Z, Ogedegbe G, Falzon L, Mann DM. Meta-analysis: impact of drug class on adherence to antihypertensives. Circulation. 2011;123(15):1611–21.
‹‹95››. Messerli FH, Bangalore S. Half a century of hydrochlorothiazide: facts, fads, fiction, and follies. Am J Med. 2011;124(10):896–9.
‹‹96››. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665.
‹‹97››. Donnison CP. Blood pressure in the African native. Lancet. 1929;213(5497):6–7.
‹‹98››. Morse WR, McGill MD, Beh YT. Blood pressure amongst aboriginal ethnic groups of Szechwan Province, West China. Lancet. 1937;229(5929):966–8.
‹‹99››. Sacks FM, Kass EH. Low blood pressure in vegetarians: Effects of specific foods and nutrients. Am J Clin Nutr. 1988;48(3 Suppl):795–800.
‹‹100››. Go AS, Bauman MA, Coleman King SM, et al. An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention. J Am Coll Cardiol. 2014; 63(12): 1230–8.
‹‹101››. Sharma AM, Schorr U. Dietary patterns and blood pressure. N Engl J Med. 1997;337(9):637.
‹‹102››. Chen Q, Turban S, Miller ER, Appel LJ. The effects of dietary patterns on plasma renin activity: results from the Dietary Approaches to Stop Hypertension trial. J Hum Hypertens. 2012; 26(11):664–9.
‹‹103››. Sacks FM, Rosner B, Kass EH. Blood pressure in vegetarians. Am J Epidemiol. 1974;100(5): 390–8.
‹‹104››. Donaldson AN. The relation of protein foods to hypertension. Cal West Med. 1926;24(3):328–31.
‹‹105››. Appel LJ, Brands MW, Daniels SR, et al. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension. 2006;47(2): 296–308.
‹‹106››. Sacks FM, Obarzanek E, Windhauser MM, et al. Rationale and design of the Dietary Approaches to Stop Hypertension trial (DASH). A multicenter controlled-feeding study of dietary patterns to lower blood pressure. Ann Epidemiol. 1995;5(2):108–18.
‹‹107››. Karanja NM, Obarzanek E, Lin PH, et al. Descriptive characteristics of the dietary patterns used in the Dietary Approaches to Stop Hypertension trial. DASH Collaborative Research Group. J Am Diet Assoc. 1999;99(8 Suppl):S19–27.
‹‹108››. Sacks FM, Kass EH. Low blood pressure in vegetarians: Effects of specific foods and nutrients. Am J Clin Nutr. 1988;48(3 Suppl):795–800.
‹‹109››. de Paula TP, Steemburgo T, de Almeida JC, Dall’Alba V, Gross JL, de Azevedo MJ. The role of Dietary Approaches to Stop Hypertension (DASH) diet food groups in blood pressure in type 2 diabetes. Br J Nutr. 2012;108(1):155–62.
‹‹110››. Yokoyama Y, Nishimura K, Barnard ND, et al. Vegetarian diets and blood pressure: a metaanalysis. JAMA Intern Med. 2014;174(4):577–87.
‹‹111››. Le LT, Sabat? J. Beyond meatless, the health effects of vegan diets: findings from the Adventist cohorts. Nutrients. 2014;6(6):2131–47.
‹‹112››. Fraser GE. Vegetarian diets: what do we know of their effects on common chronic diseases? Am J Clin Nutr. 2009;89(5):1607S–1612S.
‹‹113››. Tonstad S, Stewart K, Oda K, Batech M, Herring RP, Fraser GE. Vegetarian diets and incidence of diabetes in the Adventist Health Study-2. Nutr Metab Cardiovasc Dis. 2013;23(4):292–9.
‹‹114››. Fraser GE. Vegetarian diets: what do we know of their effects on common chronic diseases? Am J Clin Nutr. 2009;89(5):1607S–1612S.
‹‹115››. Fontana L, Meyer TE, Klein S, Holloszy JO. Long-term low-calorie low-protein vegan diet and endurance exercise are associated with low cardiometabolic risk. Rejuvenation Res. 2007; 10(2):225–34.
‹‹116››. Rodriguez-Leyva D, Weighell W, Edel AL, et al. Potent antihypertensive action of dietary flaxseed in hypertensive patients. Hypertension. 2013;62(6):1081–9.
‹‹117››. Cornelissen VA, Buys R, Smart NA. Endurance exercise beneficially affects ambulatory blood pressure: a systematic review and meta-analysis. J Hypertens. 2013;31(4):639–48.
‹‹118››. Geleijnse JM. Relation of raw and cooked vegetable consumption to blood pressure: the INTERMAP study. J Hum Hypertens. 2014;28(6):343–4.
‹‹119››. Jayalath VH, de Souza RJ, Sievenpiper JL, et al. Effect of dietary pulses on blood pressure: a systematic review and meta-analysis of controlled feeding trials. Am J Hypertens. 2014; 27(1): 56–64.
‹‹120››. Chiva-Blanch G, Urpi-Sarda M, Ros E, et al. Dealcoholized red wine decreases systolic and diastolic blood pressure and increases plasma nitric oxide: short communication. Circ Res. 2012;111(8):1065–8.
‹‹121››. Figueroa A, Sanchez-Gonzalez MA, Wong A, Arjmandi BH. Watermelon extract supplementation reduces ankle blood pressure and carotid augmentation index in obese adults with prehypertension or hypertension. Am J Hypertens. 2012;25(6):640–3.
‹‹122››. Gammon CS, Kruger R, Brown SJ, Conlon CA, von Hurst PR, Stone house W. Daily kiwifruit consumption did not improve blood pressure and markers of cardiovascular function in men with hypercholesterolemia. Nutr Res. 2014;34(3):235–40.
‹‹123››. Anderson JW, Weiter KM, Christian AL, Ritchey MB, Bays HE. Raisins compared with other snack effects on glycemia and blood pressure: a randomized, controlled trial. Postgrad Med. 2014;126(1):37–43.
‹‹124››. Akhtar S, Ismail T, Riaz M. Flaxseed-a miraculous defense against some critical maladies. Pak J Pharm Sci. 2013;26(1):199–208.
‹‹125››. Rodriguez-Leyva D, Weighell W, Edel AL, et al. Potent antihypertensive action of dietary flaxseed in hypertensive patients. Hypertension. 2013;62(6):1081–9.
‹‹126››. Ninomiya T, Perkovic V, Turnbull F, et al. Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials. BMJ. 2013;347:f5680.
‹‹127››. Goyal A, Sharma V, Upadhyay N, Gill S, Sihag M. Flax and flaxseed oil: an ancient medicine & modern functional food. J Food Sci Technol. 2014;51(9):1633–53.
‹‹128››. Carlsen MH, Halvorsen BL, Holte K, et al. The total antioxidant content of more than 3100 foods, beverages, spices, herbs and supplements used worldwide. Nutr J. 2010;9:3.
‹‹129››. Frank T, Netzel G, Kammerer DR, et al. Consumption of Hibiscus sabdariffa L. aqueous extract and its impact on systemic antioxidant potential in healthy subjects. J Sci Food Agric. 2012; 92(10):2207–18.
‹‹130››. Chang HC, Peng CH, Yeh DM, Kao ES, Wang CJ. Hibiscus sabdariffa extract inhibits obesity and fat accumulation, and improves liver steatosis in humans. Food Funct. 2014;5(4):734–9.
‹‹131››. Mozaffari-Khosravi H, Jalali-Khanabadi BA, Afkhami-Ardekani M, Fatehi F. Effects of sour tea (Hibiscus sabdariff a) on lipid profile and lipoproteins in patients with type II diabetes. J Altern Complement Med. 2009;15(8):899–903.
‹‹132››. Aziz Z, Wong SY, Chong NJ. Effects of Hibiscus sabdariffa L. on serum lipids: a systematic review and meta-analysis. J Ethnopharmacol. 2013;150(2):442–50.
‹‹133››. Lin T-L. Lin H-H, Chen C–C, et al. Hibiscus sabdariffa extract reduces serum cholesterol in men and women. Nutr Res. 2007;27:140–5.
‹‹134››. Hopkins AL, Lamm MG, Funk JL, Ritenbaugh C. Hibiscus sabdariffa L. in the treatment of hypertension and hyperlipidemia: a comprehensive review of animal and human studies. Fitoterapia. 2013;85:84–94.
‹‹135››. McKay DL, Chen CY, Saltzman E, Blumberg JB. Hibiscus sabdariffa L. tea (tisane) lowers blood pressure in prehypertensive and mildly hypertensive adults. J Nutr. 2010;140(2):298–303.
‹‹136››. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206–52.
‹‹137››. McKay DL, Chen CY, Saltzman E, Blumberg JB. Hibiscus sabdariffa L. tea (tisane) lowers blood pressure in prehypertensive and mildly hypertensive adults. J Nutr. 2010;140(2):298–303.
‹‹138››. Herrera-Arellano A, Flores-Romero S, Ch?vez-Soto MA, Tortoriello J. Effectiveness and tolerability of a standardized extract from Hibiscus sabdariffa in patients with mild to moderate hypertension: a controlled and randomized clinical trial. Phytomedicine. 2004;11(5): 375–82.
‹‹139››. US Food and Drug Administration. CAPOTEN® (Captopril Tablets, USP) http://www.accessdata. fda.gov/drugsatfda_docs/label/2012/018343s084lbl.pdf. Accessed March 19, 2015.
‹‹140››. Hendricks JL, Marshall TA, Harless JD, Hogan MM, Qian F, Wefel JS. Erosive potentials of brewed teas. Am J Dent. 2013;26(5):278–82.
‹‹141››. Malik J, Frankova A, Drabek O, Szakova J, Ash C, Kokoska L. Aluminium and other elements in selected herbal tea plant species and their infusions. Food Chem. 2013;139(1–4):728–34.
‹‹142››. F?rstermann U. Janus-faced role of endothelial NO synthase in vascular disease: uncoupling of oxygen reduction from NO synthesis and its pharmacological reversal. Biol Chem. 2006; 387(12):1521–33.
‹‹143››. Franzini L, Ardig? D, Valtue?a S, et al. Food selection based on high total antioxidant capacity improves endothelial function in a low cardiovascular risk population. Nutr Metab Cardiovasc Dis. 2012;22(1):50–7.
‹‹144››. Webb AJ, Patel N, Loukogeorgakis S, et al. Acute blood pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via bioconversion to nitrite. Hypertension. 2008; 51(3):784–90.
‹‹145››. Smith RE, Ashiya M. Antihypertensive therapies. Nat Rev Drug Discov. 2007;6(8):597–8.
‹‹146››. Kapil V, Khambata RS, Robertson A, Caulfield MJ, Ahluwalia A. Dietary nitrate provides sustained blood pressure lowering in hypertensive patients: a randomized, phase 2, doubleblind, placebo-controlled study. Hypertension. 2015;65(2):320–7.
‹‹147››. Wylie LJ, Kelly J, Bailey SJ, et al. Beetroot juice and exercise: pharmacodynamic and dose-response relationships. J Appl Physiol. 2013;115(3):325–36.
‹‹148››. European Food Safety Authority. Nitrate in vegetables: scientific opinion of the panel on contaminants in the food chain. EFSA J. 2008;689:1–79.
‹‹149››. Murphy M, Eliot K, Heuertz RM, Weiss E. Whole beetroot consumption acutely improves running performance. J Acad Nutr Diet. 2012;112(4):548–52.
‹‹150››. Clements WT, Lee SR, Bloomer RJ. Nitrate ingestion: a review of the health and physical performance effects. Nutrients. 2014;6(11):5224–64.
‹‹151››. Hord NG, Tang Y, Bryan NS. Food sources of nitrates and nitrites: the physiologic context for potential health benefits. Am J Clin Nutr. 2009;90(1):1–10.
‹‹152››. Bhupathiraju SN, Wedick NM, Pan A, et al. Quantity and variety in fruit and vegetable intake and risk of coronary heart disease. Am J Clin Nutr. 2013;98(6):1514–23.
‹‹153››. Tamakoshi A, Tamakoshi K, Lin Y, Yagyu K, Kikuchi S. Healthy lifestyle and preventable death: findings from the Japan Collaborative Cohort (JACC) Study. Prev Med. 2009;48(5):486–92.
‹‹154››. Wang F, Dai S, Wang M, Morrison H. Erectile dysfunction and fruit/vegetable consumption among diabetic Canadian men. Urology. 2013;82(6):1330–5.
‹‹155››. Presley TD, Morgan AR, Bechtold E, et al. Acute effect of a high nitrate diet on brain perfusion in older adults. Nitric Oxide. 2011;24(1):34–42.
‹‹156››. Engan HK, Jones AM, Ehrenberg F, Schagatay E. Acute dietary nitrate supplementation improves dry static apnea performance. Respir Physiol Neurobiol. 2012;182(2–3):53–9.
‹‹157››. Bailey SJ, Winyard P, Vanhatalo A, et al. Dietary nitrate supplementation reduces the O2 cost of low- intensity exercise and enhances tolerance to high-intensity exercise in humans. J Appl Physiol. 2009;107(4):1144–55.
‹‹158››. Murphy M, Eliot K, Heuertz RM, Weiss E. Whole beetroot consumption acutely improves running performance. J Acad Nutr Diet. 2012;112(4):548–52.
‹‹159››. Lidder S, Webb AJ. Vascular effects of dietary nitrate (as found in green leafy vegetables and beetroot) via the nitrate-nitrite-nitric oxide pathway. Br J Clin Pharmacol. 2013;75(3):677–96.
‹‹160››. Wylie LJ, Kelly J, Bailey SJ, et al. Beetroot juice and exercise: pharmacodynamic and dose-response relationships. J Appl Physiol. 2013;115(3):325–36.